Drugging the Undruggable
| Title: | Drugging the Undruggable |
|---|---|
| Description: |
A clinical trial showed that sotorasib controlled non-small cell lung cancer in about 80% of patients with the G12C KRAS mutation. https://www.cancer.gov/research/annual-plan/scientific-topics/undruggable-targets This image is part of the NCI Annual Plan and Budget Proposal FY 2024 collection. See also www.cancer.gov/research/annual-plan. |
| Type: | Color, Illustration (JPEG format) |
| Source: | Nation Cancer Institute (NCI) |
| Creator: | Nation Cancer Institute (NCI) |
| Date Created: | August 18, 2022 |
| Date Added: | September 14, 2022 |
| Reuse Restrictions: | None - This image is in the public domain and can be freely reused. Please credit the source and, where possible, the creator listed above. |